PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC13138602::ACT044665

Phoenixin-14 amide

Evidence text

Paper-level observation

While the PNX-14 (2.5 nmol) group showed a mild increase (0.73 ± 0.05-fold), the PNX-14 (5 nmol) group demonstrated a moderate restoration of PCNA levels (0.91 ± 0.07-fold). In contrast, the PNX-14 (30 nmol) group displayed lower PCNA expression (0.65 ± 0.08-fold).
textConfidence: medium

Assay observation

Activity
Metabolic/Cardiovascular
Subtype
Other
Measure
other
Comparator
=
Raw observation
0.91 ± 0.07-fold
Normalized measurement
=0.91 fold
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Rattus norvegicus
Assay method
Not reported by source
Sequence
DVQPPGLKVWSDPFNH
Standardization
ready simple

Source publication

Phoenixin-14 ameliorates ovarian morphology in a DHEA-induced rat model of PCOS

Reproduction & Fertility · 2026

DOI 10.1530/RAF-25-0142 PMC13138602
Parent mention

Related peptide identities

PEPDIA-PLP-000501

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.